IJCRRI Journ Cur Res ReInternational Journal of Current Research and ReviewI Journ Cur Res Re2231-21960975-5241Radiance Research Academy1009HealthcareCEREBROVASCULAR ATTACK: NEW THERAPEUTIC AREAS OF INTEREST SahaPartha S.16122013)3136This article is copyright of Popeye Publishing, 20092009This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.

Cerebrovascular attack (CVA) or stroke is one of the leading causes of adult disability in world. The current treatments of the stroke are preventive treatment, acute-phase stroke treatment and post-stroke rehabilitation. But the need of more sophisticated therapies and the drawbacks of the existing therapies in their usages call for the new therapies to replace them or develop them. This essay summarizes some of the major new therapeutic approaches, such as the use of statin agents, ACE-I, vitamins, minocycline, edaravone, other neuroprotective agents, stem cell therapy and hyperbaric oxygen therapy. It also describes new methods of implanting of Penumbra system for prevention of the stroke.

Stroke penumbra system minocycline in stroke edaravone in stroke ReN001 stem cell therapy hyperbaric oxygen therapy.